Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastric mucus barrier is an essential multi-layered defense system comprised mainly of secreted gel-forming mucins trapping neutralizing agents above tightly joined epithelia—together ensuring safe containment/functionality amid harsh digestive conditions while preventing self-injury. It consists of a mucus layer (primarily composed of mucins), bicarbonate secretion, and a tightly joined epithelial cell lining. Its main functions include physical and chemical protection, pH regulation, and anti-bacterial action. Disruption can lead to conditions like peptic ulcer disease and gastritis, often exacerbated by factors like H. pylori infection, NSAIDs, and alcohol.
N/A - This is a barrier system, not a single target with a specific mechanism of action.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric Mucus Barrier (GMB).